Roche holding ag stock

Roche and its innovative U. Roche's immuno-oncology drug Tecentriq was launched third to market behind Bristol's Opdivo and Merck's Keytruda, raising questions about Roche's innovation. Morningstar brands and products. Investing Ideas.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech.

Roche holding ag stock

This means our website may not look and work as you would expect. Read more about browsers and how to update them here. Invest now. To buy shares in , you'll need to have an account. Explore the options. All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions. The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation. You are here:. Sell:

Roche and its innovative U. All markets data located on FT. Roche's immuno-oncology drug Tecentriq was launched third to market behind Bristol's Opdivo and Merck's Keytruda, raising questions about Roche's innovation.

One can take advantage of the trading range to enter new positions. Add to a list Add to a list. To use this feature you must be a member. Market Closed - Swiss Exchange Other stock markets. Funds and ETFs. Last Hours! Enjoy this offer.

CHF Key events shows relevant news articles on days with large price movements. Novartis AG. NOVN 0. Nestle SA. NESN 0. Pfizer Inc. PFE 1.

Roche holding ag stock

Key events shows relevant news articles on days with large price movements. Yahoo Finance. Roche Holding AG Genussscheine.

Anchor 6 amp switch price

Recently viewed investments. Exchange disclaimer. Sector Healthcare. Show more World link World. Cancel Continue. Search the FT Search. Show more Tech link Tech. Start Free Trial. To buy shares in , you'll need to have an account. Total Yield 3. Deal now. Health Care Pharmaceuticals and Biotechnology.

Roche and its innovative U. Roche's immuno-oncology drug Tecentriq was launched third to market behind Bristol's Opdivo and Merck's Keytruda, raising questions about Roche's innovation.

Stock Style Box Large Core. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities. The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. Funds and ETFs. Short selling activity Low. Open Recently viewed shares. Short selling activity Low. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities. Quick Ratio. Financial Times Close. Year high : Industry Drug Manufacturers - General.